ReviewInternal and emergency medicine2026

GLP-1 receptor agonists at the crossroads of diabetes, hepatic steatosis, and hepatocellular carcinoma.

Alfredo Vozza et al.PubMed ↗Publisher ↗

No numbers read from the abstract.